Gilead Sciences, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
GILD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
333 Lakeside Dr, Foster City, CA

Insiders trading volume in the past year

Gilead Sciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Daniel P. O'Day Chairman & CEO, Director $96.1M Mar 10, 2025
Andrew D. Dickinson Chief Financial Officer $25.2M -$54.9M -68.5% Apr 15, 2025
Johanna Mercier Chief Commercial Officer $22M -$4.06M -15.6% Mar 10, 2025
Merdad Parsey Chief Medical Officer $21.1M -$19.5M -48.1% Dec 10, 2024
Deborah H. Telman EVP, Corporate Affairs & GC $15M Mar 10, 2025
Kevin E. Lofton Director $8.76M Mar 28, 2024
Olsen Per Wold Director $8.75M May 6, 2021
Sandra Patterson SVP, Controllership $7.9M Mar 10, 2025
Dietmar Berger Chief Medical Officer $5.99M Mar 10, 2025
Diane E. Wilfong Interim Corp Controller & CAO $4.98M Mar 12, 2025
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel $4.17M Jun 10, 2022
Richard James Whitley Director $3.15M May 6, 2021
Jacqueline K. Barton Director $2.6M May 8, 2024
Kelly A. Kramer Director $2.15M May 8, 2024
Jeffrey Bluestone Director $2.09M -$620K -22.9% Nov 26, 2024
Harish Manwani Director $1.84M May 8, 2024
Javier Rodriguez Director $1.7M May 8, 2024
Anthony Welters Director $1.67M May 8, 2024
Sandra Horning Director $1.51M May 8, 2024
Ted W. Love Director $1.19M May 8, 2024

Recent Insider Transactions by Companies or Individuals for Gilead Sciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.